Preliminary Results for the year ended 30 April 2026 by chantal | Oct 9, 2026 | Latest News, Regulatory News
Publication of Circular, Notice of General Meeting and Proposed Share Consolidation by chantal | Oct 2, 2026 | Latest News, Regulatory News
Scancell Receives UK MHRA Clinical Trial Authorization for Phase 3 Registrational Trial of iSCIB1+ in Advanced Melanoma by chantal | Aug 19, 2026 | iSCIB1+, Latest News, Regulatory News
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing by admin | Jul 23, 2026 | Latest News, Regulatory News
Scancell Receives FDA Fast Track Designation for iSCIB1+ by chantal | Apr 28, 2026 | iSCIB1+, Latest News, Regulatory NewsWelcome to WordPress. This is your first post. Edit or delete it, then start writing!
